LIFT study is discontinuedBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7542.667 (Published 16 March 2006) Cite this as: BMJ 2006;332:667
- Steven R Cummings, director (firstname.lastname@example.org)
- California Pacific Medical Center, San Francisco, CA 94105, USA
EDITOR—We informed the BMJ about the increased risk of stroke in the long term intervention on fractures with tibolone (LIFT) study.1 Further analysis now indicates a benefit of tibolone on risk of vertebral fracture, the primary end point of the study. Thus, the LIFT study is being stopped because of a recommendation by the data safety monitoring board that the trial has reached its objectives and additional follow-up is …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial